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ABSTRACT 
 
Background: Obesity is an important health problem among developed and developing countries. Magnesium (Mg) 
deficiency is seen in obese individuals. Aim: To investigate the effect of Mg deficiency on insulin resistance in obese 
subjects. Methods: In this retrospective study, patients admitted to our hospital between 1 January 2016 and 31 December 
2016 were included and data were retrieved from their medical records. We collected values of HbA1c, Mg, Glucose and 
Homa-IR and other biochemical tests. According to Body Mass Index (BMI), patients were divided into 3 groups. The 
relationship between Mg level and BMI was analyzed. Meanwhile, we also observed the relation between insulin resistance 
and BMI and relation between Hba1c and BMI. Results: A total of 134 patients, 21 male and 113 female, were included in 
the study. There was no statistical significance in serum Mg levels between the groups and there was a weak negative 
correlation between BMI and serum Mg levels. The correlation between BMI and insulin resistance was found to be 
moderately positive. On comparing, BMI and HbA1c between groups; it was statistically significant the groups consisting of 
BMIs below 25 and between 25-35, and the groups consisting of BMIs below 25 and >35. There was moderate positive 
correlation between BMIs and HbA1c levels. A negligible positive correlation between Mg levels and insulin resistance was 
observed. A weak negative correlation was found between Mg and HBA1C levels. Conclusion: Serum MG deficiency can be 
seen in obese individuals. Low serum Mg levels may accelerate the development of diabetes in obese individuals. 
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besity has become an important health problem in 
developed and developing countries. Dietary 
intake of high calories decreased physical activity 
and sedentary life plays a role in the development of 
obesity. Increased body weight can lead to diseases such as 
type 2 diabetes, cardiovascular disease, hypertension and 
cancer [1]. In the development of obesity, environmental 
and genetic factors are thought to be influenced by neuro 
endocrine mechanisms regulating energy balance [2]. 
Magnesium (Mg) is the second common cation in 
extracellular and intracellular fluids. It is also a cofactor of 
nucleic acid and protein synthesis [3].  
Mg is necessary to maintain normal muscle and nerve 
function as well as the heart rhythm and bone integrity. It 
is also responsible for protein synthesis and energy 
metabolism. Mg deficiency frequently developed by; 
urinary system disease causing Mg loss and lack of Mg 
absorption due to gastrointestinal system disease and 
chronically low uptake of Mg [4]. In previous study, it was 
observed that Mg replacement may play a role in decrease 
of insulin resistance and diabetes [5]. Insulin resistance; is 
defined as an impaired biological response to endogenous 
or exogenous insulin [6]. According to the Turkish 
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Diseases Prevalence Study-II (TURDEP-II) data published 
in 2010, the prevalence of obesity in Turkey has reached 
32% in the adult age group. Compared to TURDEP I study 
data in 1998, obesity in our country increased by 44% in 
12 years and increase was 34% in women and 107% in 
men [7]. Studies have shown that magnesium intake is 
significantly correlated with steatosis, insulin resistance, 
hyperinsulinemia, hypertriglyceridemia, low HDL 
cholesterol and hypertension [8]. In this study, we aim to 
show the relationship between serum Mg level and insulin 
resistance in young obese individuals. 
METHODS 
This retrospective study was conducted between January 1, 
2016 and December 31, 2016 in the University Research 
Hospital patients who were followed up and treated in the 
internal clinics and were directed to a dietician. All 
patients who applied to the hospital with any complaint 
were included in the study in which 21 were male and 113 
female patients. Patients with known diabetes, metabolic 
disease with liver and kidney dysfunction were excluded 
from the study. This study was ethical approved by 
Amasya University Sabuncuoğlu Serefeddin Education 
and Research Hospital (Amasya, Turkey) in the scientific 
meeting at 29.04.2016. 
Demographic profile and data of included patients were 
retrieved from their medical records. After examining the 
patients’ data, 3 groups were formed based on their BMI. 
First group consist of patients whom BMI were under 25. 
The second group consist of patients whose BMI is 
between 25 and 35. The third group consist of patients 
whose BMI is upper 35. The BMI <25 was considered to 
be normal, between 25- 29.9 was overweight people and if 
it was >30, the person was said to be obese. The 
relationship between Mg level and BMI was analyzed. 
Meanwhile, we also observed the relation between insulin 
resistance and BMI and relation between Hba1c and BMI. 
Insulin resistance was calculated by; HOMA index (fasting 
insulin (pmol/l) x fasting plasma glucose (mg/dL) / 405) 
and BMI calculated by; Body Weight (kg) / Squared 
Length (m2) formula. Serum Mg (normal values: 1.9 - 2.5 
ng / ml) was studied in the Olimpus AU 5800 by direct 
method in which magnesium ions form a complex with 
xylidine blue. Serum insulin measurements (normal 
values: 2,6-37,6 pmol/l) were performed on the Siemens 
Advia Centaur xp with electrochemiluminescence method. 
Serum glucose measurements (normal values: 74- 109 
mg/dl) were performed on the Olympus AU 5800 
instrument using the glucose oxidase method. HBA1C 
measurements (normal values: 4-6%) were performed on 
the Trinity / Menarini Premier device by HPLC boranat 
method. 
GraphPad Prism version7.00 was used for statistical 
analysis. (GraphPad Software, La Jolla California USA). 
One-Way ANOVA was used to compare quantitative data 
while the multiple logistic regression analysis was 
performed to investigate how dependent variables were 
affected by independent variables. The Chi-Square test 
was used to understand gender differences. The results 
were evaluated in 95% confidence interval and 
significance level of p <0.01. Correlation between the 
parameters was done by Pearson correlation analysis. 
Correlation coefficient (r) was evaluated as weak between 
0.00-0.24, moderate between 0.25-0.49, strong between 
0.50-0.74, very strong relation between 0.75-1.00. 
RESULTS 
Total 134 people were included in this study and the mean 
Mg level was 1.7±2.2 mg/ dl and Hba1c level  was  4-6. In 
our study, 32 (23.8%) of the participants had BMI  <25, 84 
(62.6%) patients had BMI between 25-35 and 18 (13.4%) 
patients had BMI >35 and over. 10 of the patients with 
BMI <25 (31.25%) were male and 22 (59.75%) were 
female. 8 (9.5%) of the patients with BMI between 25 and 
35 were male and 76 (90.5%) were female. There were 3 
male (16.6%)  and 15 (83.4%) female with BMI 35 and 
over. Table 1 shows the gender differences in BMI. 
Although there is a difference between the genders, there 
is no difference between male and female groups by one 
way Anova  (p> 0,05). 








Gender n % n % n %     
Female 22 59.75 76 90.5 15 83.4 
8.29 0.015 
Male 10 31.25 8 9.5 3 16.6 




resistance BMI HBA1C 
Mg 
r 1 0.014 -0.149 -0.053 
p -- 0.870 0.085 0.543 
Insulin 
resistance 
r 0.014 1 0.277 0.141 
p 0.870 -- 0.001 0.104 
BMI 
r -0.149 0.277 1 0.385 
p 0.085 0.001 -- 0.0004 
HBA1C 
r -0.053 0.141 0.385 1 
p 0.543 0.104 0.0004 -- 
There was a weak negative correlation between BMI 
and Mg levels (r = -0,149, p <0,085). Also, there was a 
moderate positive correlation between BMI and insulin 
resistance (r = 0.277 p <0.001) and a moderate positive 
correlation between BMI and HBA1C levels (r = 0.385, p 
<0.0004). A negligible positive correlation between Mg 
and insulin resistance was observed (r = 0.014, p <0.870). 
There was a weak negative correlation between Mg and 
HBA1C (r = -0.053, p <0.543) and a weak positive 
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correlation between insulin resistance and HBA1C (r = 
0.141, p <0.104) (Table 2).  
 
Fig 1: Mg level of among the BMI groups 
   
Fig 2: Levels of Insulin Resistance among BMI groups 
      
Fig 3: HbA1C levels between BMI groups 
There was no statistical significance between the 
groups (P>0,05) according to the levels of Mg levels 
among the BMI groups (Figure 1). Levels of insulin 
resistance among BMI groups were not statistically 
significant (P> 0.05) (Figure 2). HbA1c levels between 
BMI groups had following outcomes: BMI between 25-35 
group is statistically significant with the group that 
constitutes the BMI <25 (p=0.0007), and the group with 
BMI >35 is statistically significant than the group that had 
patients with BMI <25 (p <0.0001), (Figure 3).  
The linear regression analysis showed the following 
observations:  2.2% of BMI is attributed to an increase in 
MG levels (r2 = 0.02234, p = 0.0848) (Figure 4); a very 
low increase in insulin resistance is attributed to a 0.2% 
increase in MG levels (r2 = 0.000203, p = 0.8702) (Figure 
5); and0.2% of the change in HA1C levels is attributed to 
the increase in MG levels (r2 = 0.002803, p <0.5435) 
(Figure 6). 
 
Fig 4: Linear regression analysis between BMI & Mg 
 
Fig 5: Linear regression analysis between insulin 
resistance and Mg 
   
Fig 6: Linear regression analysis between HA1C & Mg 
DISCUSSION 
Mg may play a role in pancreatic insulin secretion, insulin 
action in peripheral tissues, and glucose homeostasis and 
many mechanisms have been presented to support this fact.  
Firstly; it is the cofactor for many critical enzymes that use 
high-energy phosphate bonds in glucose metabolism. It has 
been observed that reduced Mg levels increase intracellular 
Ca levels, decrease insulin signalling, decrease troxin 
kinase activity in insulin receptor. Therefore, intracellular 
Mg levels are important in maintaining insulin sensitivity 
in adipose tissue and skeletal muscle. In addition, 
intracellular Mg levels can affect insulin secretion 
stimulated by glucose by altering the pro inflammatory 
response, endothelial function, oxidative stress, and 
cellular iron metabolism in pancreatic cells [9].  
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In a previous study, dietary magnesium intake was 
found to be inadequate in non-diabetic individuals with 
metabolic syndrome. Dietary magnesium intake has a 
protective effect on insulin resistance [10]. Changes in the 
cellular Mg, and may alter glucose entry into the cell, 
leading to insulin resistance development [11]. Another 
study investigated whether oral mg supplementation 
improves insulin sensitivity and metabolic control in 
patients with low Mg levels in type 2 diabetes. Total 63 
patients with type 2 diabetes whose serum Mg levels were 
low and who were using glibenclamide, were included in 
the study. As a result, in Mg supplemented patients, 
HOMA-IR index, fasting glucose levels, and HBA1C 
levels were lower compared to control group. Decreased 
Mg levels in patients with type 2 diabetes are important in 
the development of metabolic control of type 2 diabetes 
and insulin sensitivity [12]. 
In a study, hypomagnesaemia is found to be associated 
with the development of impaired glucose tolerance and  
type 2 diabetes [13]. Plasma and intracellular Mg 
concentration is strictly regulated by many factors. The 
most important of these seem to be insulin. Invitro and in 
vivo studies show that insulin has been implicated in the 
passage of Mg into the extracellular and intracellular 
space. Intracellular Mg concentration has been shown to be 
effective in regulating insulin action.  
Insulin independent type 2 diabetes and hypertensive 
patients have low intracellular Mg concentration. This may 
result in defective tyrosine kinase activity at the insulin 
receptor level and exogenous intracellular Ca activity. In 
the case of insulin independent type 2 diabetes, daily Mg 
supplementation creates a more favourable intracellular 
Mg concentration and contributes to insulin-mediated 
glucose uptake. Several studies have shown that Mg may 
play a key role in vascular tone and insulin-mediated 
glucose uptake [14]. 
In a study of 4637 patients, the risk of developing 
metabolic syndrome was lower in people with high Mg 
intake [15]. Takaya J et al showed that Mg is necessary for 
glucose metabolism and utilization and Mg deficiency is 
associated with insulin resistance [16]. The relationship 
between obesity and Mg is not clear. Various studies have 
evaluated the relationship between BMI and Mg uptake in 
adults, but the results are still controversial [17]. There is a 
relationship between Mg deficiency and IR in children. In 
obese children, serum magnesium deficiency may be 
developed as a secondary due to reduced Mg intake in diet. 
Mg supplementation may be important in protecting from 
type 2 diabetes in obese children [18]. In a study 
conducted on 276 white South Asian and 315 Canadian 
women, the relationship between serum Mg 
concentrations, DM, glucose control, IR and BMI was 
investigated. Serum Mg concentration was lower in both 
sexes and in females of South Asian females. Serum Mg 
and racial differences were not significant after being 
checked for diabetes drug use. The use of diabetes 
medications, bad glucose control indicators, insulin 
resistance, and obesity were thought to be associated with 
low Mg levels in women [19]. The incidence of type 2 
diabetes is thought to be inversely related to Mg. These 
findings have suggested that consumption of Mg-rich 
foods such as cereals, beans, nuts, and green leafy 
vegetables may reduce the risk of type 2 diabetes [20]. 
If we look at another study, serum Mg levels in the 
obese group with insulin resistance were significantly 
lower as compared to the  control group. At the same time, 
there was a positive correlation between serum Mg level 
and BMI deviation score in obese patients. Low serum 
magnesium levels may contribute to the development of 
insulin resistance in obese children [21]. In a study of 
536318 participants, 24.516 patients had a significant 
inverse relationship between Mg intake and type 2 diabetes 
risks. This was not observed in normal weight subjects 
when a significant inverse relationship was detected in 
overweight subjects. These differences were not 
statistically significant [22]. More than 1 million 
individuals were studied in 40 studies ranging the age 
group of 4 to 30 years. The relationship between increased 
dietary Mg and total cardiovascular disease was observed 
in these study groups. It was observed that Mg intake was 
associated with decreased cardiac insufficiency, stroke, 
type 2 diabetes and all-cause mortality [23]. The 
relationship between Mg, type 2 diabetes and lipid profile 
was evaluated. Two grups were made consistig of 50 
control groups and 50 patient groups were included in the 
study. There was a negative correlation between serum Mg 
levels and fasting blood glucose levels and lipid profiles 
[24].  
Fat tissue is considered as an endocrine organ; it 
produces reactive oxygen species that cause lipid 
peroxidation. Mg deficiency causes oxidative stress 
development. This mineral is the cofactor of many 
enzymes. It is effective in the cell membrane stability. Mg 
acts as antioxidant. Low Mg was found as a marker of high 
oxidative stress in obese individuals [25]. 
In a study of Libiyan patients, 100 type 2 diabetes and 
50 control groups were studied to measure serum Mg 
levels. According to the control group, a significant 
decrease in Mg was observed in patients with Libyan 
diabetic patients. There was a significant negative 
correlation between serum Mg levels and HBA1C levels 
and duration of diabetes. There was a negative correlation 
between fasting plasma glucose and Mg levels. There was 
no correlation between Mg levels and age [26]. Increased 
levels of Mg in our study were among the BMI groups. No 
statistical significance was found between the groups. 
There is a correlation between BMI and Mg levels in the 
weak negative direction. This suggests in the unlikely 
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event that Mg deficiency may lead to weight gain in 
individuals. There is no statistical significance between the 
levels of insulin resistance among the BMI groups. Again, 
there was a moderate positive correlation between BMI 
and insulin resistance. This was thought to be due to 
decreased insulin sensitivity in obesity-related peripheral 
tissues. 
Levels of HBA1C between BMI groups; the group 
consisting of 25-35 of BMI, was statistically significant 
with the group consisting of the lower than 25 of the BMI, 
and the group consisting of over 35 was statistically 
significant with the group consisting of BMI lower  25. 
There was a moderate positive correlation between BMI 
and HBA1C levels. This increase may be due to increased 
insulin resistance due to obesity and consequently 
increased HBA1C levels with increased blood sugar in 
individuals. A negligible positive correlation between Mg 
levels and insulin resistance was observed. This is because 
our study is conducted as a retrospective data search, so 
there is no information about the dietary patterns and 
lifestyle of the patients. A weak negative correlation was 
found between Mg and HBA1C levels. Elevated serum Mg 
level may help control blood glucose levels. Accordingly, 
it may have caused the HBA1C level to decrease. It is 
thought to be arising from reduced glucose transit in the 
cells and increased blood glucose levels due to increased 
insulin resistance. 
Since this study was conducted retrospectively, there 
were certain limitations to this study. Among these, 
information on the amount of Mg intake in the diet, which 
may affect the serum Mg levels of patients, could not be 
obtained from patient records. There was no availability 
information about the patients' lifestyles and daily physical 
activity. Another important issue is whether Mg deficiency 
contributes to the development of obesity or whether Mg 
levels have changed depending on obesity-related eating 
habits. For the elucidation of these issues, there is a need 
for more patients and more detailed information from the 
patients. 
CONCLUSION 
In conclusion, Mg deficiency can be seen in obese 
individuals, although our findings are not very strong. Low 
serum Mg levels may contribute to the development of 
diabetes in obese individuals. We cannot fully understand 
the contribution of low serum Mg levels to the 
development of diabetes in obese individuals. Therefore, 
when the patient benefit and the treatment cost of these 
diseases are taken into account, serum Mg levels should be 
determined by routine controls and necessary treatment 
should be done in obese individuals. This can delay 
obesity and the development of diabetes in individuals. It 
may be useful in the treatment of obesity. 
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